Unnatural Products raised $45 million in Series B financing to advance its macrocyclic peptide therapeutics.
- Amount
- $45M
- Stage
- Series B
- Announced
- 16 March 2026
- Use of funds
- To advance macrocyclic peptide therapeutics
- Checked
- Amount and date checked against the press source